Braidwell LP Exact Sciences Corp Transaction History
Braidwell LP
- $1.79 Billion
- Q4 2024
A detailed history of Braidwell LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Braidwell LP holds 353,000 shares of EXAS stock, worth $17.4 Million. This represents 1.11% of its overall portfolio holdings.
Number of Shares
353,000
Previous 286,178
23.35%
Holding current value
$17.4 Million
Previous $19.5 Billion
99.9%
% of portfolio
1.11%
Previous 0.55%
Shares
3 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
164MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$864 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$838 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$594 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$594 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$307 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.72B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...